Michael Blum

Michael Blum

Company: Homology Medicines

Job title: Vice President, Commercial Strategy


Early Commercial Strategy for Rare Indications 3:30 pm

• Exploring best practice for trial indication selection • Setting up an early commercial strategy that works to maximize the commercial potential of your therapeutic • Approval and Reimbursement 101: Key strategic lessons that are imperative to achieve commercial successRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.